An integrated proteomic and bioinformatic approach identifies a subset of EGFR-expressing epithelial ovarian cancer

被引：0
|
作者：
Pinciroli, Patrizia [1 ]
Alberti, Chiara [1 ]
Sensi, Marialuisa [1 ]
Ferri, Renata [1 ]
Valeri, Barbara [1 ]
Canevari, Silvana [1 ]
Tomassetti, Antonella [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4930
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Genomic profile associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with epidermal growth factor receptor (EGFR) inhibitor cetuximab.
    Zhang, W
    Vallböhmer, D
    Yang, D
    Yun, J
    Press, OA
    Gordon, M
    Rhodes, K
    Sherrod, A
    Iqbal, S
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 260S - 260S
  • [42] Proteomic analysis for early detection of ovarian cancer: A realistic approach?
    Stevens, EV
    Liotta, LA
    Kohn, EC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 : 133 - 139
  • [43] A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines
    Di Michele, Michela
    Della Corte, Anna
    Cicchillitti, Lucia
    Del Boccio, Piero
    Urbani, Andrea
    Ferlini, Cristiano
    Scambia, Giovanni
    Donati, Maria Benedetta
    Rotilio, Domenico
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (02): : 225 - 236
  • [44] A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
    Albert, Susann
    Arndt, Claudia
    Feldmann, Anja
    Bergmann, Ralf
    Bachmann, Dominik
    Koristka, Stefanie
    Ludwig, Florian
    Ziller-Walter, Pauline
    Kegler, Alexandra
    Gaertner, Sebastian
    Schmitz, Marc
    Ehninger, Armin
    Cartellieri, Marc
    Ehninger, Gerhard
    Pietzsch, Hans-Juergen
    Pietzsch, Jens
    Steinbach, Joerg
    Bachmann, Michael
    ONCOIMMUNOLOGY, 2017, 6 (04):
  • [45] Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer
    Wu, Wenjuan
    Wang, Qi
    Yin, Fuqiang
    Yang, Zhijun
    Zhang, Wei
    Gabra, Hani
    Li, Li
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1651 - 1665
  • [46] Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology
    Chow, S. N.
    Chen, R. J.
    Chen, C. H.
    Chang, T. C.
    Chen, L. C.
    Lee, W. J.
    Shen, J.
    Chow, L. P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (01) : 55 - 62
  • [47] A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
    Hartmann, J. T.
    Kollmannsberger, C.
    Cascorbi, I.
    Mayer, F.
    Schittenhelm, M. M.
    Heeger, S.
    Bokemeyer, C.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 661 - 668
  • [48] A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
    J. T. Hartmann
    C. Kollmannsberger
    I. Cascorbi
    F. Mayer
    M. M. Schittenhelm
    S. Heeger
    C. Bokemeyer
    Investigational New Drugs, 2013, 31 : 661 - 668
  • [49] Integrated transcriptomics and histopathology approach identifies a subset of rejected donor livers with potential suitability for transplantation
    Srivastava, Ankita
    Manchel, Alexandra
    Waters, John
    Ambelil, Manju
    Barnhart, Benjamin K.
    Hoek, Jan B.
    Shah, Ashesh P.
    Vadigepalli, Rajanikanth
    BMC GENOMICS, 2024, 25 (01):
  • [50] Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
    Lin Cheng
    Kun Zhang
    Yunan Qing
    Dong Li
    Manhua Cui
    Peng Jin
    Tianmin Xu
    Journal of Ovarian Research, 13
12345